These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 25320514)

  • 1. Current issues and future perspectives of gastric cancer screening.
    Hamashima C
    World J Gastroenterol; 2014 Oct; 20(38):13767-74. PubMed ID: 25320514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update version of the Japanese Guidelines for Gastric Cancer Screening.
    Hamashima C;
    Jpn J Clin Oncol; 2018 Jul; 48(7):673-683. PubMed ID: 29889263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric cancer: prevention, screening and early diagnosis.
    Pasechnikov V; Chukov S; Fedorov E; Kikuste I; Leja M
    World J Gastroenterol; 2014 Oct; 20(38):13842-62. PubMed ID: 25320521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and harms of endoscopic screening for gastric cancer.
    Hamashima C
    World J Gastroenterol; 2016 Jul; 22(28):6385-92. PubMed ID: 27605874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice.
    Quach DT; Hiyama T; Gotoda T
    World J Gastroenterol; 2019 Jul; 25(27):3546-3562. PubMed ID: 31367156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forthcoming Step in Gastric Cancer Prevention: How Can Risk Stratification Be Combined with Endoscopic Screening for Gastric Cancer?
    Hamashima C
    Gut Liver; 2022 Nov; 16(6):811-824. PubMed ID: 35314519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for and surveillance of gastric cancer.
    Compare D; Rocco A; Nardone G
    World J Gastroenterol; 2014 Oct; 20(38):13681-91. PubMed ID: 25320506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of endoscopic screening on mortality reduction from gastric cancer.
    Hamashima C; Ogoshi K; Narisawa R; Kishi T; Kato T; Fujita K; Sano M; Tsukioka S
    World J Gastroenterol; 2015 Feb; 21(8):2460-6. PubMed ID: 25741155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Have we Comprehensively Evaluated the Effectiveness of Endoscopic Screening for Gastric Cancer?
    Hamashima C
    Asian Pac J Cancer Prev; 2015; 16(8):3591-2. PubMed ID: 25921183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of two serological methods in screening gastric cancer and its precancerous condition].
    Li MY; Zhang DQ; Lu X; Chen WC
    Zhonghua Nei Ke Za Zhi; 2018 Dec; 57(12):907-911. PubMed ID: 30486559
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
    Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
    Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions.
    Shafaghi A; Mansour-Ghanaei F; Joukar F; Sharafkhah M; Mesbah A; Askari K; Geranmayeh S; Mehrvarz A; Souti F; Sokhanvar H; Fakhrieh S; Aminian K; Yousefi-Mashhour M; Khosh-Sorur M; Rasoulian J
    Asian Pac J Cancer Prev; 2013; 14(6):3931-6. PubMed ID: 23886209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of
    Kowada A
    Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges in evaluation of screening for gastric cancer among men based on nonrandomized design.
    Vohlonen I; Härkönen M; Malila N; Pukkala E; Sipponen P; Koistinen V; Hakama M
    Acta Oncol; 2017 Jul; 56(7):917-922. PubMed ID: 28514928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.
    Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Long Q; Flanders WD; Bostick RM; Yuan Y
    Int J Cancer; 2015 Jan; 136(2):425-34. PubMed ID: 24895149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and surveillance for gastric cancer in the United States: Is it needed?
    Kim GH; Liang PS; Bang SJ; Hwang JH
    Gastrointest Endosc; 2016 Jul; 84(1):18-28. PubMed ID: 26940296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group.
    Varis K; Sipponen P; Laxén F; Samloff IM; Huttunen JK; Taylor PR; Heinonen OP; Albanes D; Sande N; Virtamo J; Härkönen M
    Scand J Gastroenterol; 2000 Sep; 35(9):950-6. PubMed ID: 11063155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Precancerous conditions and lesions of the stomach].
    Falt P; Hanousek M; Kundrátová E; Urban O
    Klin Onkol; 2013; 26 Suppl():S22-8. PubMed ID: 24325159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is screening and surveillance for early detection of gastric cancer needed in Korean Americans?
    Kim GH; Bang SJ; Ende AR; Hwang JH
    Korean J Intern Med; 2015 Nov; 30(6):747-58. PubMed ID: 26552450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.
    Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Bostick RM; Wu X; Yuan Y
    Am J Gastroenterol; 2017 May; 112(5):704-715. PubMed ID: 28323271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.